Creative Planning’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.06M Buy
47,485
+3,454
+8% +$82.5K ﹤0.01% 2411
2025
Q4
$1.18M Buy
44,031
+7,682
+21% +$184K ﹤0.01% 2166
2025
Q3
$776K Buy
36,349
+7,274
+25% +$172K ﹤0.01% 2354
2025
Q2
$627K Sell
29,075
-11,569
-28% -$215K ﹤0.01% 2260
2025
Q1
$675K Sell
40,644
-4,310
-10% -$78.3K ﹤0.01% 2033
2024
Q4
$825K Buy
44,954
+19,893
+79% +$321K ﹤0.01% 1804
2024
Q3
$385K Buy
25,061
+10,441
+71% +$174K ﹤0.01% 2323
2024
Q2
$238K Buy
+14,620
New +$236K ﹤0.01% 2546
2024
Q1
Sell
-7,243
Closed -$227K 2916
2023
Q4
$227K Buy
+7,243
New +$173K ﹤0.01% 2316
2022
Q4
Sell
-13,202
Closed -$216K 2490
2022
Q3
$216K Sell
13,202
-810
-6% -$13.1K ﹤0.01% 1859
2022
Q2
$197K Sell
14,012
-6,803
-33% -$127K ﹤0.01% 1888
2022
Q1
$504K Buy
20,815
+6,525
+46% +$158K ﹤0.01% 1317
2021
Q4
$334K Buy
14,290
+334
+2% +$6.72K ﹤0.01% 1547
2021
Q3
$232K Sell
13,956
-935
-6% -$18K ﹤0.01% 1764
2021
Q2
$363K Sell
14,891
-740
-5% -$16.7K ﹤0.01% 1453
2021
Q1
$403K Sell
15,631
-14,122
-47% -$622K ﹤0.01% 1584
2020
Q4
$1.59M Buy
29,753
+3,105
+12% +$154K ﹤0.01% 754
2020
Q3
$1.1M Buy
26,648
+15,026
+129% +$649K ﹤0.01% 761
2020
Q2
$563K Sell
11,622
-2,100
-15% -$101K ﹤0.01% 972
2020
Q1
$580K Sell
13,722
-16,400
-54% -$676K ﹤0.01% 870
2019
Q4
$1.29M Sell
30,122
-3,019
-9% -$131K ﹤0.01% 674
2019
Q3
$1.19M Sell
33,141
-1,225
-4% -$37.1K ﹤0.01% 686
2019
Q2
$919K Buy
34,366
+28
+0.1% +$715 ﹤0.01% 788
2019
Q1
$922K Sell
34,338
-1,320
-4% -$30.8K ﹤0.01% 762
2018
Q4
$577K Buy
35,658
+5,876
+20% +$114K ﹤0.01% 886
2018
Q3
$618K Sell
29,782
-54,825
-65% -$863K ﹤0.01% 972
2018
Q2
$1.29M Buy
84,607
+12,073
+17% +$215K 0.01% 611
2018
Q1
$1.63M Buy
72,534
+220
+0.3% +$6.09K 0.01% 521
2017
Q4
$2.18M Buy
72,314
+24,503
+51% +$784K 0.01% 433
2017
Q3
$1.8M Buy
47,811
+22,896
+92% +$745K 0.01% 498
2017
Q2
$695K Buy
24,915
+1,159
+5% +$34.5K ﹤0.01% 853
2017
Q1
$817K Sell
23,756
-8,000
-25% -$282K ﹤0.01% 750
2016
Q4
$916K Buy
31,756
+19,625
+162% +$519K 0.01% 660
2016
Q3
$386K Buy
12,131
+4,479
+59% +$152K ﹤0.01% 1030
2016
Q2
$248K Buy
7,652
+1,950
+34% +$65.3K ﹤0.01% 1149
2016
Q1
$159K Buy
5,702
+200
+4% +$4.36K ﹤0.01% 1335
2015
Q4
$196K Buy
5,502
+1,775
+48% +$62.5K ﹤0.01% 1206
2015
Q3
$123K Buy
+3,727
New +$155K ﹤0.01% 1473
2015
Q2
Sell
-3,525
Closed -$115K 1115
2015
Q1
$115K Hold
3,525
﹤0.01% 1502
2014
Q4
$112K Sell
3,525
-3,000
-46% -$85.1K ﹤0.01% 1494
2014
Q3
$162K Buy
6,525
+3,000
+85% +$70.2K ﹤0.01% 1178
2014
Q2
$80K Sell
3,525
-14,300
-80% -$299K ﹤0.01% 1572
2014
Q1
$434K Buy
17,825
+15,525
+675% +$393K 0.01% 685
2013
Q4
$57K Hold
2,300
﹤0.01% 1510
2013
Q3
$63K Buy
2,300
+2,000
+667% +$41.8K ﹤0.01% 1373
2013
Q2
$5K Buy
+300
New +$4.13K ﹤0.01% 2521

Other funds holding ACAD